Skip to content

Molecular characteristic and immune microenvironment of primary colorectal signet ring cell carcinoma: A retrospective study

Molecular characteristic and immune microenvironment of primary colorectal signet ring cell carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072881
Enrollment
Unknown
Registered
2023-06-27
Start date
2023-02-13
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal signet ring cell carcinoma

Interventions

colorectal signet ring cell:no
colorectal adneocarcinoma:no

Sponsors

Shanxi Provincial Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who obtain informed consent prior to implementing any trial-related procedures 2. Aged 18 to 75 3. Have clinically and pathologically confirmed primary colorectal indolent cell carcinoma (=50% indolent cell component) 4. Complete clinicopathological data available. 5. The availability of sufficient histological specimens for testing

Exclusion criteria

Exclusion criteria: 1. Diagnosed with a cancer other than colorectal cancer within 5 years 2. Have a medical history or evidence of disease that may interfere with the results of the trial, prevent the subject from participating in the study in its entirety, have abnormal treatment or laboratory test results, or have other conditions that, in the investigator's opinion, make the subject unsuitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
mutation landscape;

Secondary

MeasureTime frame
tumor immune microenvironment;mIHC;

Countries

China

Contacts

Public ContactYanfeng Xi

Shanxi Provincial Cancer Hospital

xiyanfeng1998@163.com+86 139 3421 1344

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026